Please try another search
Kidswell Bio Corp, formerly Gene Techno Science Co Ltd, is a Japan-based company mainly engaged in the development of biopharmaceuticals. The biosimilar business is engaged in the research, development and provision of filgrastim biosimilar products and pegfilgrastim biosimilar products for cancer, darbepoetin alfa biosimilar products for renal diseases, and ranibizumab biosimilar products for eye diseases. The new biopharmaceutical business is engaged in the research and development of anti-RAMP2 antibodies for cancer and eye diseases, as well as new antibodies. The new biotechnology business is engaged in the development of regenerative medicine products that utilize intracardiac stem cells for pediatric congenital heart diseases, and regenerative medicine products that utilize dental pulp stem cells for cleft lip and palate and intestinal ganglion cell deficiency diseases, as well as the joint research business with universities.
Name | Age | Since | Title |
---|---|---|---|
Masato Mori | 58 | 2010 | Outside Audit & Supervisory Board |
Hiroshi Shinagawa | 47 | 2020 | Outside Audit & Supervisory Board Member |
Shinya Kurebayashi | 47 | 2019 | President, CEO & Representative Director |
Osamu Sugawara | 65 | 2020 | Full-time Audit & Supervisory Board Member |
Norikazu Eiki | 75 | 2018 | Independent Outside Director |
Masayuki Kawakami | 60 | 2018 | Corporate Officer of Research & Development Division and Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review